Who is sponsoring NCT04151147?

NCT04151147 is sponsored by Ege University.

What drugs are being tested in NCT04151147?

Interventions in NCT04151147: Concentrated Growth Factor (Test group), Non-Concentrated Growth Factor (Control group).

What condition does NCT04151147 study?

NCT04151147 studies Alveolar Osteitis, Impacted Tooth.

Is NCT04151147 still recruiting?

NCT04151147 is currently completed. Last updated 5 November 2019.

Last reviewed 2019-11-05 · How we verify

NCT04151147

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of CGF on Frequency of Alveolar Osteitis Following Partially Erupted Mandibular Third Molar Surgery

Completed NA Last updated 5 November 2019

What this trial tests

NA trial testing Concentrated Growth Factor (Test group) in Alveolar Osteitis in 70 participants. Completed in 30 July 2018.

Timeline

2 January 2018

Primary endpoint
15 July 2018

30 July 2018

Quick facts

Lead sponsor	Ege University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	70
Start date	2 January 2018
Primary completion	15 July 2018
Estimated completion	30 July 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Concentrated Growth Factor (Test group)
Non-Concentrated Growth Factor (Control group)

Conditions studied

Alveolar Osteitis — all drugs for Alveolar Osteitis →
Impacted Tooth — all drugs for Impacted Tooth →

Sponsor

Ege University

Who can join

Adults 18 to 65, any sex, with Alveolar Osteitis or Impacted Tooth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this prospective study was to assess the effectiveness of concentrated growth factors (CGFs) in preventing the development of alveolar osteitis (AO) after the extraction of partially-erupted mandibular third molars. This study was designed as a randomized controlled clinical trial. In each case, one socket received CGFs and the other served as a control. The predictor variable was the CGFs application and the sides were categorized as 'CGFs' and 'non-CGFs'. The outcome variable was the development of AO during the first postoperative week. Also, demographic variable included age and gender was noted.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of concentrated growth factors on frequency of alveolar Osteitis following partially-erupted mandibular third molar surgery: a randomized controlled clinical study.
Özveri Koyuncu B, Işık G, Özden Yüce M, Günbay S, et al · · 2020 · cited 14× · PMID 32807173 · DOI 10.1186/s12903-020-01210-7

Verify or expand the search:

Other recruiting trials for Alveolar Osteitis

Currently open trials in the same condition.

NCT06435832 — Evaluations of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence · NA · active not recruiting

Other Ege University trials

Trials by the same sponsor.

NCT07468227 — Effect of Helfer Skin Tap and Vibration on Pain and Fear in Children During Intramuscular Injection · NA · not yet recruiting
NCT07473050 — Virtual Reality-Based 'Health at My Feet' Program for Individuals With Type 2 Diabetes · NA · not yet recruiting
NCT06955338 — Music and VR Effects on Pain, Anxiety, and Fear During Oral Mucositis Care in Leukaemic Children · NA · not yet recruiting
NCT07344532 — Effect of Preoperative Abdominal Effleurage on Postoperative Constipation · NA · not yet recruiting
NCT07417748 — Kinesthetic Exercises on Adults · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04151147 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ege University
Last refreshed: 5 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04151147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing